Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme

por Zannad, Faiez, Ferreira, João Pedro, Butler, Javed, Filippatos, Gerasimos, Januzzi, James L, Sumin, Mikhail, Zwick, Matthias, Saadati, Maral, Pocock, Stuart J, Sattar, Naveed, Anker, Stefan D, Packer, Milton
Publicado 2022

Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction: A Post Hoc Analysis of the EMPEROR-Preserved Trial

por Butler, Javed, Usman, Muhammad Shariq, Filippatos, Gerasimos, Ferreira, João Pedro, Böhm, Michael, Brueckmann, Martina, Januzzi, James L., Kaul, Sanjay, Piña, Ileana L., Ponikowski, Piotr, Senni, Michele, Sumin, Mikhail, Verma, Subodh, Zaremba-Pechmann, Liliana, Pocock, Stuart J., Packer, Milton, Anker, Stefan
Publicado 2023

Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction

por Butler, Javed, Filippatos, Gerasimos, Siddiqi, Tariq Jamal, Ferreira, João Pedro, Brueckmann, Martina, Bocchi, Edimar, Böhm, Michael, Chopra, Vijay K., Giannetti, Nadia, Iwata, Tomoko, Januzzi, James L., Kaul, Sanjay, Piña, Ileana L., Ponikowski, Piotr, Rauch-Kröhnert, Ursula, Shah, Sanjiv J., Senni, Michele, Sumin, Mikhail, Verma, Subodh, Zhang, Jian, Pocock, Stuart J., Zannad, Faiez, Packer, Milton, Anker, Stefan D.
Publicado 2022